Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
Clinical trial NCT01366521 · COMPLETED
Trial details
- NCT number
- NCT01366521
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2012-03-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.